Q5109 Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg

Short descriptor: Injection, ixifi, 10 mg

⚠ Terminated HCPCS Level II 2026
Terminated Code
Q5109 was terminated as of 2025-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open Q5109 in the app →

Look up Q5109 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q5109 is the HCPCS Level II code for Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2026-01-01
Termination Date
2025-12-31
2026 Maintenance
Discontinued

References

Cite This Page

Reference Q5109 with the canonical source and edition:

Q5109 — Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q5109

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q5109

Related Codes in Section Q

← Q5108 Injection, fulphila Q5110 → Nivestym
Q5105 Inj retacrit esrd on dialysi Q5106 Inj retacrit non-esrd use Q5107 Inj mvasi 10 mg Q5108 Injection, fulphila Q5110 Nivestym Q5111 Injection, udenyca 0.5 mg Q5112 Inj ontruzant 10 mg Q5113 Inj herzuma 10 mg Q5114 Inj ogivri 10 mg Q5115 Inj truxima 10 mg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial